Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Levy

Showing results (1221-1230 of 1,312) with videos related to

Pageof 132
Sort By:
Science (New York, N.Y.)|March 29, 1974
Venus: mass, gravity field, atmosphere, and ionosphere as measured by the mariner 10 dual-frequency radio systemH T Howard, G L Tyler, G Fjeldbo, et al.
British Journal of Haematology|March 14, 2013
The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosisSrdan Verstovsek, Ruben A Mesa, Jason Gotlib, et al.
Journal of Neuro-Oncology|August 24, 2024
Metabolic signatures derived from whole-brain MR-spectroscopy identify early tumor progression in high-grade gliomas using machine learningCameron A Rivera, Shovan Bhatia, Alexis A Morell, et al.
Epilepsia|March 20, 2015
Epilepsy in Rett syndrome--lessons from the Rett networked databaseAndreea Nissenkorn, Rachel S Levy-Drummer, Ori Bondi, et al.
The New England Journal of Medicine|March 2, 2012
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosisSrdan Verstovsek, Ruben A Mesa, Jason Gotlib, et al.
Haematologica|September 17, 2013
Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-ISrdan Verstovsek, Ruben A Mesa, Jason Gotlib, et al.
Science (New York, N.Y.)|July 12, 1974
Mercury: results on mass, radius, ionosphere, and atmosphere from mariner 10 dual-frequency radio signalsH T Howard, G L Tyler, P B Esposito, et al.
Muscle & Nerve|December 10, 2021
A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosisMerit E Cudkowicz, Stacy R Lindborg, Namita A Goyal, et al.
Journal of Neurosurgery|March 6, 2026
Therapeutic management of intracranial internal carotid artery blowout syndrome: an institutional case series and individual participant data meta-analysisRomil Singh, Fernando Terry, Nihas Mateti, et al.
Muscle & Nerve|April 9, 2024
Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomesStacy R Lindborg, Namita A Goyal, Jonathan Katz, et al.
Pageof 132

Showing results (1221-1230 of 1,312) with videos related to

Sort By:
Pageof 132
Science (New York, N.Y.)|March 29, 1974
Venus: mass, gravity field, atmosphere, and ionosphere as measured by the mariner 10 dual-frequency radio systemH T Howard, G L Tyler, G Fjeldbo, et al.
British Journal of Haematology|March 14, 2013
The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosisSrdan Verstovsek, Ruben A Mesa, Jason Gotlib, et al.
Journal of Neuro-Oncology|August 24, 2024
Metabolic signatures derived from whole-brain MR-spectroscopy identify early tumor progression in high-grade gliomas using machine learningCameron A Rivera, Shovan Bhatia, Alexis A Morell, et al.
Epilepsia|March 20, 2015
Epilepsy in Rett syndrome--lessons from the Rett networked databaseAndreea Nissenkorn, Rachel S Levy-Drummer, Ori Bondi, et al.
The New England Journal of Medicine|March 2, 2012
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosisSrdan Verstovsek, Ruben A Mesa, Jason Gotlib, et al.
Haematologica|September 17, 2013
Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-ISrdan Verstovsek, Ruben A Mesa, Jason Gotlib, et al.
Science (New York, N.Y.)|July 12, 1974
Mercury: results on mass, radius, ionosphere, and atmosphere from mariner 10 dual-frequency radio signalsH T Howard, G L Tyler, P B Esposito, et al.
Muscle & Nerve|December 10, 2021
A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosisMerit E Cudkowicz, Stacy R Lindborg, Namita A Goyal, et al.
Journal of Neurosurgery|March 6, 2026
Therapeutic management of intracranial internal carotid artery blowout syndrome: an institutional case series and individual participant data meta-analysisRomil Singh, Fernando Terry, Nihas Mateti, et al.
Muscle & Nerve|April 9, 2024
Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomesStacy R Lindborg, Namita A Goyal, Jonathan Katz, et al.
Pageof 132